Kite Pharma, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$1.16B

943 transactions

Summary

Kite Pharma, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $5.8MSales: $199.6M21 insiders

Date	Insider	Type	Value
2017-10-03	Belldegrun Arie(Chairman, President and CEO)	D	$289.4M
2017-10-03	Belldegrun Arie(Chairman, President and CEO)	D	$90.0M
2017-10-03	Belldegrun Arie(Chairman, President and CEO)	D	$90.0M
2017-10-03	Belldegrun Arie(Chairman, President and CEO)	D	$77.4M
2017-10-03	Belldegrun Arie(Chairman, President and CEO)	D	$28.7M
2017-10-03	BUTITTA CYNTHIA M(Chief Operating Officer)	D	$19.8M
2017-10-03	Belldegrun Arie(Chairman, President and CEO)	D	$12.3M
2017-10-03	BUTITTA CYNTHIA M(Chief Operating Officer)	D	$7.9M
2017-10-03	BUTITTA CYNTHIA M(Chief Operating Officer)	D	$6.6M
2017-10-03	Belldegrun Arie(Chairman, President and CEO)	D	$5.1M
2017-10-03	BUTITTA CYNTHIA M(Chief Operating Officer)	D	$3.4M
2017-10-03	Belldegrun Arie(Chairman, President and CEO)	D	—
2017-10-03	Belldegrun Arie(Chairman, President and CEO)	D	—
2017-10-03	Belldegrun Arie(Chairman, President and CEO)	D	—
2017-10-03	Belldegrun Arie(Chairman, President and CEO)	D	—
2017-10-03	BUTITTA CYNTHIA M(Chief Operating Officer)	D	—
2017-10-03	BUTITTA CYNTHIA M(Chief Operating Officer)	D	—
2017-10-03	BUTITTA CYNTHIA M(Chief Operating Officer)	D	—
2017-10-03	BUTITTA CYNTHIA M(Chief Operating Officer)	D	—
2017-10-03	BUTITTA CYNTHIA M(Chief Operating Officer)	D	—

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Kite Pharma, Inc. — Contributions, Lobbying & Contracts | Poliscope